Clinical Trials Update: Aug. 20, 2008
Multiple Sclerosis
Psoriasis
Rhinitis, Allergic, Perennial
|
E-mail this article
Subscribe to news
Printer friendly version
|
(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:
Multiple Sclerosis
If you are aged 18 to 55 and have a confirmed diagnosis of relapsing-remitting multiple sclerosis with at least one relapse in the past 12 months, you may qualify for this study.
The research site is in Round Rock, Texas.
More information
Please see http://www.centerwatch.com/patient/studies/cat102.html. 
-----
Psoriasis
If you are 18-75 years old, have plaque psoriasis despite at least four months of treatment with etanercept, and have psoriatic target lesions that have a PGA score greater than one at screening, you may qualify for this study.
The research site is in San Diego, Calif.
More information
Please see http://www.centerwatch.com/patient/studies/cat126.html.
-----
Rhinitis, Allergic, Perennial
If your child is aged 6 months to 11 months, has symptoms of allergic rhinitis, and has been treated with antihistamines or is a candidate for such treatment, the child may be eligible for this study.
The research site is located in Albany, Ga.
More information
Please see http://www.centerwatch.com/patient/studies/cat804.html.
-----
Copyright 2008 CenterWatch. All rights reserved.
Copyright © 2008 ScoutNews, LLC. All rights reserved.
HealthDayNews articles are derived from various sources and do not reflect federal policy. healthfinder.gov does not endorse opinions, products, or services that may appear in news stories. For more information on health topics in the news, visit the healthfinder.gov health library.